Blockade of KATP Channels Reduces Endothelial Hyperpolarization and Leukocyte Recruitment upon Reperfusion After Hypoxia

1 Mascia L Mastromauro I Viberti S Vincenzi M Zanello M Management to optimize organ procurement in brain dead donors. Minerva Anestesiol 74 2008 1 9 Mascia L, Mastromauro I, Viberti S, Vincenzi M, Zanello M. Management to optimize organ procurement in brain dead donors. Minerva Anestesiol 2008; 74: 1–9. 2 Pratschke J Weiss S Neuhaus P Pascher A Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation. Transpl Int 21 2008 512 522 Pratschke J, Weiss S, Neuhaus P, Pascher A. Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation. Transpl Int 2008; 21: 512–522. 3 Weiss S Kotsch K Francuski M Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 7 2007 1584 1593 Weiss S, Kotsch K, Francuski M et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007; 7: 1584–1593. 4 Gourishankar S Jhangri GS Cockfield SM Halloran PF Donor tissue characteristics influence cadaver kidney transplant function and graft survival but not rejection. J Am Soc Nephrol. 14 2003 493 499 Gourishankar S, Jhangri GS, Cockfield SM, Halloran PF. Donor tissue characteristics influence cadaver kidney transplant function and graft survival but not rejection. J Am Soc Nephrol 2003; 14: 493–499. 5 Ojo AO Wolfe RA Held PJ Port FK Schmouder RL Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 63 1997 968 974 Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968–974. 6 Mikhalski D Wissing KM Ghisdal L Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 85 2008 S3 S9 Mikhalski D, Wissing KM, Ghisdal L et al. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 2008; 85: S3–S9. 7 Girn HR Ahilathirunayagam S Mavor AI Homer-Vanniasinkam S Reperfusion syndrome: Cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovascular Surg 41 2007 277 293 Girn HR, Ahilathirunayagam S, Mavor AI, Homer-Vanniasinkam S. Reperfusion syndrome: Cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovascular Surg 2007; 41: 277–293. 8 Farmer DG Anselmo D Da Shen X Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation 80 2005 828 835 Farmer DG, Anselmo D, Da Shen X et al. Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation 2005; 80: 828–835. 9 Ichikawa H Flores S Kvietys PR Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res. 81 1997 922 931 Ichikawa H, Flores S, Kvietys PR et al. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res 1997; 81: 922–931. 10 Kvietys PR Granger DN Endothelial cell monolayers as a tool for studying microvascular pathophysiology. Am J Physiol 273 1997 G1189 G1199 Kvietys PR, Granger DN. Endothelial cell monolayers as a tool for studying microvascular pathophysiology. Am J Physiol 1997; 273: G1189–G1199. 11 Cassie S Masterson MF Polukoshko A Viskovic MM Tibbles LA Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic Biol Med 36 2004 1102 1111 Cassie S,MastersonMF, Polukoshko A, Viskovic MM, Tibbles LA. Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic Biol Med 2004; 36: 1102–1111. 12 Millar TM Phan V Tibbles LA ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase-dependent neutrophil recruitment. Free Radic Biol Med 42 2007 1165 1177 Millar TM, Phan V, Tibbles LA. ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase-dependent neutrophil recruitment. Free Radic Biol Med 2007; 42: 1165–1177. 13 Erdogan A Schaefer MB Kuhlmann CR Activation of Ca2+ -activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis 190 2007 100 105 Erdogan A, Schaefer MB, Kuhlmann CR et al. Activation of Ca2+ -activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis 2007; 190: 100–105. 14 Epps DE Wolfe ML Groppi V Characterization of the steady-state and dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)trimethine oxonol (Dibac4(3)) in model systems and cells. Chem Phys Lipids 69 1994 137 150 Epps DE,Wolfe ML, Groppi V. Characterization of the steady-state and dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)trimethine oxonol (Dibac4(3)) in model systems and cells. Chem Phys Lipids 1994; 69: 137–150. 15 Yamada A Gaja N Ohya S Usefulness and limitation of DiBAC4(3), a voltage-sensitive fluorescent dye, for the measurement of membrane potentials regulated by recombinant large conductance Ca2+-activated K+ channels in HEK293 cells. Jpn J Pharmacol 86 2001 342 350 Yamada A, Gaja N, Ohya S et al. Usefulness and limitation of DiBAC4(3), a voltage-sensitive fluorescent dye, for the measurement of membrane potentials regulated by recombinant large conductance Ca2+-activated K+ channels in HEK293 cells. Jpn J Pharmacol 2001; 86: 342–350. 16 Chakrabarti S Zee JM Patel KD Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: Novel pathways for tertiary granule release. J Leukoc Biol 79 2006 214 222 Chakrabarti S, Zee JM, Patel KD. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: Novel pathways for tertiary granule release. J Leukoc Biol 2006; 79: 214–222. 17 Kubes P Jutila M Payne D Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 95 1995 2510 2519 Kubes P, Jutila M, Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 1995; 95: 2510–2519. 18 Ostrovsky L Woodman RC Payne D Teoh D Kubes P Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 96 1997 2302 2310 Ostrovsky L,Woodman RC, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997; 96: 2302–2310. 19 Payne D Kubes P Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 265 1993 G189 G195 Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 1993; 265: G189–G195. 20 Tibbles LA Ing YL Kiefer F MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J 15 1996 7026 7035 Tibbles LA, Ing YL, Kiefer F et al. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J 1996; 15: 7026–7035. 21 Stegall MD Park WD Kim DY Covarrubias M Khair A Kremers WK Changes in intragraft gene expression secondary to ischemia reperfusion after cardiac transplantation. Transplantation 74 2002 924 930 Stegall MD, Park WD, Kim DY, Covarrubias M, Khair A, Kremers WK. Changes in intragraft gene expression secondary to ischemia reperfusion after cardiac transplantation. Transplantation 2002; 74: 924–930. 22 Hanusch C Nowak K Gill IS Hypothermic preservation of lung allograft inhibits cytokine-induced chemoattractant-1, endothelial leucocyte adhesion molecule, vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression. Clin Exp Immunol 149 2007 364 371 Hanusch C, Nowak K, Gill IS et al. Hypothermic preservation of lung allograft inhibits cytokine-induced chemoattractant-1, endothelial leucocyte adhesion molecule, vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression. Clin Exp Immunol 2007; 149: 364–371. 23 Furukawa Y Libby P Stinn JL Becker G Mitchell RN Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts. Am J Pathol 160 2002 1077 1087 Furukawa Y, Libby P, Stinn JL, Becker G, Mitchell RN. Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts. Am J Pathol 2002; 160: 1077–1087. 24 Adams DJ Hill MA Potassium channels and membrane potential in the modulation of intracellular calcium in vascular endothelial cells. J Cardiovasc Electrophysiol 15 2004 598 610 Adams DJ, Hill MA. Potassium channels and membrane potential in the modulation of intracellular calcium in vascular endothelial cells. J Cardiovasc Electrophysiol 2004; 15: 598–610. 25 Katnik C Adams DJ An ATP-sensitive potassium conductance in rabbit arterial endothelial cells. J Physiol 485 Pt 3 1995 595 606 Katnik C, Adams DJ. An ATP-sensitive potassium conductance in rabbit arterial endothelial cells. J Physiol 1995; 485 (Pt 3): 595–606. 26 Nilius B Droogmans G Ion channels and their functional role in vascular endothelium. Physiol Rev 81 2001 1415 1459 Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001; 81: 1415–1459. 27 Dal-Secco D Cunha TM Freitas A Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: Role of ATP-sensitive potassium channels. J Immunol 181 2008 4287 4298 Dal-Secco D, Cunha TM, Freitas A et al. Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: Role of ATP-sensitive potassium channels. J Immunol 2008; 181: 4287–4298. 28 Springer TA Adhesion receptors of the immune system. Nature 346 1990 425 434 Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425–434. 29 Springer TA Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76 1994 301 314 Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301–314. 30 Hattori R Hamilton KK Fugate RD McEver RP Sims PJ Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 264 1989 7768 7771 Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768–7771. 31 Gill V Doig C Knight D Love E Kubes P Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation 112 2005 2031 2039 Gill V, Doig C, Knight D, Love E, Kubes P. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation 2005; 112: 2031–2039. 32 Setiadi H McEver RP Signal-dependent distribution of cell surface P-selectin in clathrin-coated pits affects leukocyte rolling under flow. J Cell Biol 163 2003 1385 1395 Setiadi H, McEver RP. Signal-dependent distribution of cell surface P-selectin in clathrin-coated pits affects leukocyte rolling under flow. J Cell Biol 2003; 163: 1385–1395. 33 Van Mourik JA Romani de Wit T Voorberg J Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 117 2002 113 122 van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 2002; 117: 113–122. 34 Yao L Pan J Setiadi H Patel KD McEver RP Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 184 1996 81 92 Yao L, Pan J, Setiadi H, Patel KD, McEver RP. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 1996; 184: 81–92. 35 Friedewald JJ Rabb H Inflammatory cells in ischemic acute renal failure. Kidney Int 66 2004 486 491 Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486–491. 36 Nilius B Schwarz G Droogmans G Modulation by histamine of an inwardly rectifying potassium channel in human endothelial cells. J Physiol 472 1993 359 371 Nilius B, Schwarz G, Droogmans G.Modulation by histamine of an inwardly rectifying potassium channel in human endothelial cells. J Physiol 1993; 472: 359–371. 37 Rahgozar M Willgoss DA Gobe GC Endre ZH ATP-dependent K+ channels in renal ischemia reperfusion injury. Ren Fail 25 2003 885 896 Rahgozar M, Willgoss DA, Gobe GC, Endre ZH. ATP-dependent K+ channels in renal ischemia reperfusion injury. Ren Fail 2003; 25: 885–896. 38 Pompermayer K Souza DG Lara GG The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney Int 67 2005 1785 1796 Pompermayer K, Souza DG, Lara GG et al. The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney Int 2005; 67: 1785–1796. 39 Pompermayer K Amaral FA Fagundes CT Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. Eur J Pharmacol 556 2007 215 222 Pompermayer K, Amaral FA, Fagundes CT et al. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. Eur J Pharmacol 2007; 556: 215–222. 40 Kohmoto J Nakao A Stolz DB Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant 7 2007 2279 2290 Kohmoto J, Nakao A, Stolz DB et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant 2007; 7: 2279–2290. 41 Mehrabi A Mood Zh A Sadeghi M Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant 22 Suppl 8 2007 viii54 viii60 Mehrabi A, Mood Zh A, Sadeghi M et al. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant 2007; 22 (Suppl 8): viii54-viii60. 42 Chappell D Beiras-Fernandez A Hammer C Thein E In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model. Transplantation 81 2006 552 558 Chappell D, Beiras-Fernandez A, Hammer C, Thein E. In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model. Transplantation 2006; 81: 552–558. 43 Bogetti D Sankary HN Jarzembowski TM Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transplant 19 2005 507 511 Bogetti D, Sankary HN, Jarzembowski TM et al. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transplant 2005; 19: 507–511. 44 Beiras-Fernandez A Thein E Chappell D Hammer C Morphological assessment of reperfusion injury in a concordant xenogeneic primate model. Ann Transplant 8 2003 50 52 Beiras-Fernandez A, Thein E, Chappell D, Hammer C. Morphological assessment of reperfusion injury in a concordant xenogeneic primate model. Ann Transplant 2003; 8: 50–52. 45 Demirseren ME Sarici M Gokrem S Yenidunya S Protective effects of monoclonal antibody to intercellular adhesion molecule-1 in venous ischemia-reperfusion injury: Experimental study in rats. J Reconstr Microsurg 23 2007 41 44 Demirseren ME, Sarici M, Gokrem S, Yenidunya S. Protective effects ofmonoclonal antibody to intercellular adhesionmolecule-1 in venous ischemia-reperfusion injury: Experimental study in rats. J Reconstr Microsurg 2007; 23: 41–44. 46 Jayle C Milinkevitch S Favreau F Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury. Kidney Int 69 2006 1749 1755 Jayle C, Milinkevitch S, Favreau F et al. Protective role of selectin ligand inhibition in a large animal model of kidney ischemiareperfusion injury. Kidney Int 2006; 69: 1749–1755. 47 Langer R Wang M Stepkowski SM Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines. J Am Soc Nephrol 15 2004 2893 2901 Langer R, Wang M, Stepkowski SM et al. Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines. J Am Soc Nephrol 2004; 15: 2893–2901. 48 Kelly KJ Williams WW Jr Colvin RB Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97 1996 1056 1063 Kelly KJ, Williams WW Jr., Colvin RB et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056–1063. 49 Zizzi HC Zibari GB Granger DN Quantification of P-selectin expression after renal ischemia and reperfusion. J Pediatr Surg 32 1997 1010 1013 Zizzi HC, Zibari GB, Granger DN et al. Quantification of P-selectin expression after renal ischemia and reperfusion. J Pediatr Surg 1997; 32: 1010–1013. 50 Haug CE Colvin RB Delmonico FL A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55 1993 766 772 discussion 772–763 Haug CE, Colvin RB, Delmonico FL et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766–772; discussion 772–763. 51 Hourmant M Bedrossian J Durand D A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation 62 1996 1565 1570 Hourmant M, Bedrossian J, Durand D et al. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation 1996; 62: 1565–1570. 52 Salmela K Wramner L Ekberg H A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: A report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 67 1999 729 736 Salmela K, Wramner L, Ekberg H et al. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: A report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 1999; 67: 729–736. 53 Buhaescu I Segall L Goldsmith D Covic A New immunosuppressive therapies in renal transplantation: Monoclonal antibodies. J Nephrol 18 2005 529 536 Buhaescu I, Segall L, Goldsmith D, Covic A. Newimmunosuppressive therapies in renal transplantation: Monoclonal antibodies. J Nephrol 2005; 18: 529–536. 54 Dhanireddy KK Xu H Mannon RB Hale DA Kirk AD The clinical application of monoclonal antibody therapies in renal transplantation. Expert Opin Emerg Drugs 9 2004 23 37 Dhanireddy KK, Xu H, Mannon RB, Hale DA, Kirk AD. The clinical application of monoclonal antibody therapies in renal transplantation. Expert Opin Emerg Drugs 2004; 9: 23–37. 55 Vincenti F Mendez R Pescovitz M A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant 7 2007 1770 1777 Vincenti F, Mendez R, Pescovitz M et al. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant 2007; 7: 1770–1777. 56 Suntharalingam G Perry MR Ward S Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355 2006 1018 1028 Suntharalingam G, Perry MR, Ward S et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355: 1018–1028.